In a high percentage of cancer tissues including breast tumors, GRP-R is overexpressed, allowing the use of GRP-like peptides labeled with β- and/or γ-emitting radionuclides for diagnostic purposes [225,226]. Here, GRPR is linked to breast neoplasm.